Vivaldi Capital Management’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Sell |
9,406
-1,714
| -15% | -$43.9K | 0.04% | 256 |
|
|
2025
Q1 | $306K | Buy |
11,120
+2,443
| +28% | +$67.2K | 0.05% | 204 |
|
|
2024
Q4 | $243K | Buy |
8,677
+1,171
| +16% | +$32.7K | 0.04% | 238 |
|
|
2024
Q3 | $216K | Sell |
7,506
-541
| -7% | -$15.6K | 0.06% | 205 |
|
|
2024
Q2 | $219K | Sell |
8,047
-492
| -6% | -$13.4K | 0.06% | 208 |
|
|
2024
Q1 | $229K | Buy |
+8,539
| New | +$229K | 0.07% | 201 |
|